NEUROPACE INC's ticker is NPCE and the CUSIP is 641288105. A total of 25 filers reported holding NEUROPACE INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 1.6%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $54,693,410 | +116.7% | 5,621,111 | 0.0% | 77.70% | +96.4% |
| Q2 2023 | $25,238,788 | -3.2% | 5,621,111 | 0.0% | 39.56% | +2.1% |
| Q1 2023 | $26,081,955 | +211.4% | 5,621,111 | 0.0% | 38.74% | +208.7% |
| Q4 2022 | $8,375,455 | -60.3% | 5,621,111 | 0.0% | 12.55% | -69.3% |
| Q3 2022 | $21,079,000 | -24.2% | 5,621,111 | 0.0% | 40.88% | +4.6% |
| Q2 2022 | $27,824,000 | -39.7% | 5,621,111 | 0.0% | 39.09% | -13.2% |
| Q1 2022 | $46,149,000 | -18.6% | 5,621,111 | 0.0% | 45.03% | +12.5% |
| Q4 2021 | $56,661,000 | – | 5,621,111 | – | 40.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| KCK LTD. | 5,621,111 | $27,824,000 | 39.09% |
| Revelation Capital Management, LLC | 248,127 | $1,228,000 | 17.38% |
| Soleus Capital Management, L.P. | 2,334,003 | $11,553,000 | 1.80% |
| Orbimed Advisors | 4,012,281 | $19,861,000 | 0.36% |
| Opaleye Management Inc. | 90,100 | $446,000 | 0.20% |
| Nantahala Capital Management | 478,438 | $2,368,000 | 0.12% |
| Bellevue Group AG | 507,930 | $2,514,000 | 0.04% |
| Ergoteles LLC | 34,800 | $172,000 | 0.01% |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | 26,148 | $129,000 | 0.00% |
| Point72 Asset Management, L.P. | 149,199 | $739,000 | 0.00% |